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Abstract 
Rationale: Smokers may show abnormal functioning in prefrontal cortex during acute 
abstinence, reflecting deficient activity in mesocorticolimbic circuitry. Cognitive 
correlates of this putatively include impaired response inhibition and other aspects of 
executive functioning.    
Objectives: To investigate whether inhibitory control and other executive functions in 
smokers are impaired during acute abstinence relative to post-nicotine.  
Methods:  145 smokers were tested twice following overnight abstinence, once after  
nicotine and once after placebo lozenges (order counterbalanced, double-blind), on: 
an antisaccade task; a Continuous Performance Task (CPT); a delayed response 
Spatial Working Memory (SWM) task; and a verbal fluency test.    
Results: Compared with placebo, nicotine was associated with better inhibitory 
control on the antisaccade task and fewer impulsive responses to filler stimuli (motor 
errors) on the CPT; at the first assessment only, nicotine also reduced impulsive 
responses to ‘catch’ stimuli on the CPT.   However, it did not affect CPT response 
bias (an index of impulsive vs. cautious decision-making), spatial working memory, or 
verbal fluency.  
Conclusions:  Smoking abstinence appears to be associated with difficulty in 
inhibiting prepotent motor responses, and nicotine to attenuate this difficulty.  
However, more ‘cognitive’ forms of inhibitory control (e.g. decision-making) and the 
other aspects of executive function tested here appear to be unaffected.  
 
Keywords:  
Nicotine, abstinence, response inhibition, executive functioning, working memory, 
dopamine, lozenge 
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Introduction 
The ability of drugs to increase brain dopamine (DA) concentrations in the 
mesocorticolimbic (MCL) brain circuitry is considered critical for their rewarding 
effects (e.g., Di Chiara and Imperato 1988; Wise 1996).  Addiction may be 
associated with abnormal activity in these pathways: although addicts continue to 
experience acute upsurges in DA levels in response to drug ingestion (Di Ciano et al. 
1995), there is increasing evidence from PET and SPET studies that by comparison 
with non drug users, abstinent addicts have fewer DA D2 receptors and show 
decreased DA release in the striatum (Dagher et al. 2001; Volkow et al. 1997, 2004).   
 
Within the MCL system, dopaminergic neurons from the ventral tegmental area 
project diffusely throughout pre-frontal cortex (PFC). In chronic drug users, reduced 
numbers of DA D2 receptors in the striatum appear to be paralleled by reduced DA 
activity in these cortical regions (Volkow et al. 1993; 2001).  Relatedly, there is 
neuroimaging evidence that drug abusers show abnormalities in the structure and 
function of PFC, particularly orbitofrontal cortex (OFC), anterior cingulate gyrus 
(ACG; London et al. 2000; Volkow et al., 1993) and dorsolateral prefrontal cortex 
(DLPFC; Robinson et al. 2001).  The varied high-level ‘executive’ cognitive functions 
ascribed to specific sub-regions of the PFC show considerable overlap (see, e.g., 
Aron et al., 2004), but include: processing the affective value of stimuli and making 
appropriate decisions, functions commonly attributed to OFC function; the inhibition 
of automatic reflexive responses, which has been associated with ACG function; and 
monitoring of strategically guided behaviour and working memory, which have been 
shown to involve DLPFC; for more detailed reviews, see Elliott et al. (2000), Kiehl et 
al. (2000), Krawczyk (2002) and Royall et al. (2002).   
 
If PFC function, in some or all subregions, is indeed disturbed in chronic smokers,  as 
it appears to be in users of other substances, then it follows that during early 
abstinence they should show deficits in some or all of the cognitive functions 
mediated by activity in these regions. Conversely, the pharmacological ‘boost’ 
achieved via smoking a cigarette - or taking nicotine replacement therapy - should at 
least transiently enhance or normalise such functions. 
 
Informed by the neuroimaging findings, recent theories of addiction have focused on 
perturbations of cognitive processes mediated by the PFC, particularly response 
inhibition.  Jentsch and Taylor (1999) were among the first to propose that PFC 
dysfunction in chronic drug users is likely to lead to impairments in the inhibitory 
control of appetitive responses to drugs or drug-related stimuli, thereby increasing 
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their risk of relapse.  Likewise, Goldstein and Volkow’s (2002) Impaired Response 
Inhibition and Salience Attribution (I-RISA) model of addiction argues that 
dependence is associated with an overvaluing of drug reward, undervaluing of 
natural rewards, and deficits in inhibitory control over prepotent responses to drug-
related stimuli; and Lubman et al. (2004) conceptualise addiction as a compulsive 
disorder and propose that the addict’s characteristic loss of control over their drug 
use is underpinned by a failure of cortical inhibitory control mechanisms.   
 
Our group has measured inhibitory control at a basic motor level via the ability to 
suppress reflexive saccades towards peripheral visual stimuli in favour of controlled 
‘antisaccades’ in the opposite direction.  Acutely abstinent smokers made 
significantly more errors on this task than either satiated smokers or non-smokers 
(Powell et al. 2002).  Poor inhibitory response control in abstinent smokers has also 
been inferred by others based on evidence of: increased errors of commission on 
vigilance tasks (Hatsukami et al. 1989; Zack et al. 2001); less efficient inhibition of 
eye movements towards task irrelevant stimuli (Rycroft et al. 2005); and decreased 
inhibition of irrelevant material on a retrieval induced forgetting task (Edginton & 
Rusted, 2003).  Using continuous performance and go/no-go tasks, Bekker et al. 
(2005), by contrast, recently reported only minimal enhancing effects of nicotine on 
response inhibition in abstinent smokers.  Elsewhere, others have demonstrated that 
current smokers are also more likely than non-smokers to favour small but immediate 
monetary rewards over larger but delayed rewards, a pattern of responding often 
characterised as ‘impulsive’ (Bickel et al. 1999; Mitchell 1999). 
 
The neurobiological theories of addiction outlined above have focused in particular 
on deficits of inhibitory control.  There is rather inconsistent empirical evidence for 
other executive functioning deficits in smokers or people addicted to other 
substances. For example, whilst Al-Adawi and Powell (1997) found poorer verbal 
fluency (tapping volitional response generation) and reduced reversed digit span 
(tapping working memory) in abstinent compared with satiated smokers, these 
findings were not replicated in a subsequent study (Powell et al. 2002).  Several 
researchers (e.g., Bekker et al., 2005; Harte and Kanarek, 2004; Sacco et al., 2005) 
have reported reduced accuracy on the continuous performance task, which involves 
working memory and attention, during abstinence; however, although Mendrek et al. 
(2006) found that relative to non-smokers abstinent smokers were impaired in 
working memory assessed by the n-back task, their deficits were not reversed by 
smoking a single cigarette.  There are also other apparently contradictory reports.  
Using a spatial working memory (SWM) task designed specifically to tap PFC 
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function, Park et al. (2000) found smokers to show superior performance after 24 
hours abstinence compared to following recent nicotine consumption.  By contrast, 
Sacco et al. (2005) found that smokers with schizophrenia showed a SWM deficit 
after overnight abstinence, and that this was reversed by smoking. Using PET, Ernst 
et al. (2001) found that, although the working memory performance of abstaining- 
and ex-smokers was equivalent, there were differences in patterns of activation 
across brain regions, suggesting that abstinence may affect the nature of the 
underlying information-processing strategy.   
 
Whether neural and cognitive dysfunctions develop as a consequence of chronic 
smoking, or predate (and possibly pre-dispose to) heavy smoking/substance use, 
they are most likely to be apparent, or unmasked, during early abstinence. The 
present study was designed to further investigate the impact of smoking abstinence 
and acute nicotine intake on dependent smokers’ response inhibition and other 
executive functions, using a rigorously double-blinded placebo-controlled design and 
by delivering nicotine in pure form.  Based on the preceding review, the study tested 
the hypotheses that, by comparison with performance following a nicotine lozenge, 
acute abstinence (placebo lozenge condition) would be associated with: 
 
1. Decreased inhibitory control, assessed using the following measures: (a) 
accuracy of antisaccadic eye movements; (b) a criterion location measure (C) of 
response bias on a Continuous Performance Task (CPT); and (c) proportion of 
‘filler’ (to-be-ignored) trials on which a response is made (pre-emptive ‘motor 
errors’) on the CPT.  
 
2. Impairments of selected ‘other’ executive functions, specifically: (a) performance 
on the spatial working memory (SWM) task developed by Park et al. (2000); (b) 
accuracy on the CPT task (indexed by dprime), which taps the ability to 
discriminate targets from distractors (‘catch’ stimuli) and has a strong working 
memory component; and (c) verbal fluency, a widely used index of volitional 
response generation. 
 
 
Materials and methods 
Design 
In this repeated measures design, 145 smokers were each tested on two occasions a 
week apart, following overnight (12 hours) abstinence from smoking on both 
occasions.  On arrival, they received either a 4mg NiQuitin lozenge (the dose given 
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clinically to smokers who smoke within 30 minutes of waking, as did the majority of 
the present sample) or a placebo lozenge.  Both preparations were provided by 
Glaxo Smith Kline and were identical in appearance and very similar in taste.  When 
used as directed, 4mg nicotine lozenges take approximately one hour to produce 
maximum plasma concentrations averaging 10.8 ng/ml (sd: 4.7), and have a half life 
of approximately 2 hours (Choi et al. 2003).  Order of the two lozenges was 
counterbalanced, and participants were required to suck them for 30 minutes before 
commencement of testing; this gives sufficient time for nicotine to reach the 
bloodstream.  One hour into the testing session, a second ‘top-up’ lozenge, identical 
to the first, was given in order to maintain fairly stable blood nicotine levels across the 
2-hour testing session.  Both participant and experimenter were blind to experimental 
condition.   
 
In addition to the experimental measures reported here, the test battery included a 
number of indices of reward motivation and incentive salience; these are processes 
which are also theoretically likely to be affected by nicotine abstinence and 
administration.  That element of the study is fully described in another paper 
(Dawkins et al., in press).  Table 1 gives a schematic representation of the overall 
study design and the order in which all tasks were administered.   
 
Table 1 here  
 
Participants 
Participants were recruited through advertisements in local newspapers, radio 
stations, colleges, libraries and pharmacies in the South East London area, and were 
paid for their participation.  All were aged between 18 and 65, had smoked more than 
10 cigarettes a day for at least one year, reported smoking within the first hour of 
waking up in the morning, and had salivary cotinine levels (at a baseline screening) 
of at least 20ng/ml. Exclusion criteria included pregnancy, current diagnosis of 
psychiatric or neurological condition, and regular use of prescription drugs or other 
psychotropic drugs. 
 
Expired CO samples were taken prior to each experimental testing session to verify 
compliance with the abstinence requirement, with CO levels ≤ 10ppm at both time 
points required for inclusion in the study (Hughes et al 1978). 
 
Participants all gave written informed consent, and the study was approved by 
Goldsmiths College Ethics Committee.   
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 Assessment Measures 
 
Demographic information included age, gender, and years of education.  
 
Smoking status 
Self-reported use: Participants were asked how many cigarettes they smoked per 
day, how many years they had smoked, and how many quit attempts they had made. 
 
Salivary Cotinine: Participants provided a saliva sample at a preliminary screening 
assessment. Cotinine, a metabolite of nicotine and the most sensitive marker of 
recent nicotine intake with a half-life of 48 hours, was analysed by gas 
chromatography.  Regular smokers typically show salivary cotinine levels in the 
region of 330ng/ml, and non-smokers < 20ng/ml (Jarvis et al., 1987).   
 
Expired carbon monoxide.  Breath CO levels were taken at baseline and at the 
beginning of each testing session.  The half life of CO is approximately 4 hours and 
scores of < 11ppm are expected in smokers who have abstained for 12 hours 
(Hughes et al 1978). 
 
The Fagerström Test of Nicotine Dependence (FTND; Heatherton et al., 1991) 
This 6-item self-report scale assesses nicotine dependence.  Scores range from 0 
(low dependence) to 10 (high dependence).   
 
Craving and Withdrawal Symptoms: Craving for a cigarette and withdrawal 
symptoms were assessed towards the end of each session following exposure to a 
neutral stimulus in the context of a cue reactivity assessment (findings from which 
are reported in Dawkins et al., in press).  Participants rated their craving (‘How strong 
is your desire to smoke right now’) on a 7-point Likert scale ranging from 1 (not at all 
strong) to 7 (extremely strong); and, on the Mood and Physical Symptoms Scale 
(MPSS; West and Hajek 2004), the severity of seven symptoms of nicotine 
withdrawal (depression, irritability, anxiety, drowsiness, restlessness, hunger, poor 
concentration) on a 5-point scale (0-4), yielding a maximum possible score of 28 
(severe symptoms). 
  
Mood state 
Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983):  The 
HADS was administered towards the end of each session.  This instrument  
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assesses the presence and severity of symptoms of anxiety and depression over the 
preceding seven days. 7 items tap each mood state, with each item rated on a 4-
point scale (0-3) to yield total scores of between 0 and 21 for both anxiety and 
depression (higher scores indicate greater disturbance).  
 
Experimental Tasks 
Oculomotor task of response inhibition (antisaccadic eye movements):   Participants 
were required to suppress a reflexive glance towards a stimulus which appeared in 
the periphery of the visual field and instead to generate an eye movement of the 
same amplitude in the opposite direction (an antisaccade).  In a control condition, 
participants were simply required to look towards the peripheral stimulus 
(prosaccades).  The procedure used here was based on that employed by 
Fukushima et al. (1994) and Clementz et al. (1994).  Participants were tested in a 
quiet, darkened room, seated 30cm in front of a 25cm computer monitor and fitted 
with eye-tracking headgear.  A chin rest was used to minimise head movements.  
Horizontal eye movements were measured (for the left eye only) using an infra-red 
reflection technique (IRIS IR 6500 by Scalar Medical) with a sampling rate of 500 Hz.  
Recordings were then digitised using a Brain Boxes 12-bit analogue-to-digital 
converter.   
 
Following calibration, participants were asked to fixate on a centrally located white 
dot subtending a visual angle of < 0.25o for a period varying randomly between 2 and 
4 seconds.  Following a 200 msec interval after extinction of the fixation point, one of 
four possible peripheral targets was illuminated for 500 msec. The central fixation 
point then re-appeared.  Peripheral targets varied in both direction (left or right of 
central fixation) and amplitude (10° or 20°) and were presented in a randomised 
order.  In the prosaccade condition, which was always first, participants were 
instructed to “look at the peripheral target as quickly and as accurately as you can”; a 
total of 60 peripheral stimuli were then presented, 15 at each of the four possible 
positions.  After a 5-minute interval, 60 more stimuli were presented under 
antisaccade instructions (“don’t look at the peripheral target but instead, look in the 
opposite direction, i.e., to the mirror image position”).   
 
A custom program, written in-house, was used to classify each eye-movement as 
correct (initial movement in the right direction) or incorrect (initial movement in the 
wrong direction regardless of whether it is subsequently corrected).  Instances in 
which no eye movement was recorded (e.g. due to poor calibration, temporary eye 
closure or failure to elicit an eye movement of sufficient magnitude) were eliminated 
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from the analysis, and percentages correct were then computed for the remaining 
pro- and antisaccade trials.  On average, only 3.85 trials out of 60 were eliminated for 
each participant (mode = 0); however, more than half of the trials were affected for 13 
participants, because of calibration problems, and the data from these participants 
were entirely excluded on the basis that it was less likely to be reliable.     
 
Continuous Performance Task (CPT; Dougherty et al. 1999).  Versions of the CPT 
have been widely employed to study attentional control and response inhibition in a 
variety of patient groups, particularly schizophrenics (see Cohen and Servan-
Schreiber 1992).  In this version, adapted from Dougherty et al. (1999), 5-digit 
numbers were presented at a constant rate of two per second for a period of 5 
minutes.  Participants were instructed to respond by clicking the left button on a 
computer mouse whenever a 5-digit sequence was identical to the preceding one 
(‘targets’) and NOT to respond to either ‘novel’ stimuli (all 5 digits were different from 
those in previous stimulus) or ‘catch’ stimuli (where 4 of the 5 digits matched the 
preceding stimulus).  Each presentation of a target, catch, or novel stimulus was 
separated from the next by three consecutive presentations of the fixed ‘filler’ 
sequence 12345 to which participants were told NOT to respond (see Figure 1). Two 
fixed sequences were used here, with the order counterbalanced across sessions.   
 
 Figure 1 here 
 
The rate of impulsive, incorrect responses to catch stimuli (measured by commission 
errors) has been found to correlate positively with impulsive personality traits and to 
increase following consumption of alcohol (Dougherty et al., 1999).  However, the 
probability of a commission error is influenced both by the ability to discriminate 
between target and catch stimuli and by response bias; we have therefore indexed 
these influences separately using signal detection theory. Our signal detection 
analysis, using responses to targets as hits and responses to catch stimuli as false 
positives, yields: (i) an index of accuracy (‘dprime’), which taps the ability, strongly 
influenced by working memory, to discriminate targets from catch stimuli, with scores 
ranging from 0 (chance level performance) to 4 (effectively, perfect performance); 
and (ii) a criterion location measure of response bias (C) where a score of 0 reflects 
unbiased responding, a negative score reflects a liberal (and putatively impulsive) 
bias to respond on the basis of little evidence for the presence of a target (i.e. a high 
rate of both hits and false positives), and a positive score represents a cautious bias 
(fewer hits and fewer false positives).  In addition we calculated the proportion of 
trials on which a pre-emptive response was made to at least one of the sequence of 
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three filler stimuli (12345s); because participants knew in advance that these three 
stimuli, occurring as they did immediately following the target stimulus, should never 
be responded to.  We have labelled these as (impulsive) ‘motor errors’. 
 
Spatial Working Memory (SWM; Park et al. 1995).  This delayed-response SWM task 
was adapted from Park et al. (1995) from a paradigm used by Funahashi et al. 
(1989) with rhesus monkeys and shown to be sensitive to DLPFC lesions.  Similar 
impairments have been reported in patients with PFC lesions (Partiot et al., 1996), 
schizophrenics (e.g. Spitzer, 1993), and healthy individuals high in schizotypy (Park 
et al., 1995).   
 
Participants were asked to focus on a central fixation point (a small red dot) 
throughout the task.  A ‘target’ stimulus (a larger black dot) then appeared for 
200msec. in one of eight possible locations each separated by 45 degrees on the 
circumference of an imaginary circle centred on the red dot.  Participants were 
instructed simply to remember the position of this target.  The location of the target 
dot varied from trial to trial in a pseudo-randomised order with each of the eight 
locations used four times.  During a 10 second interval between target presentation 
and response, a distractor task was presented in which participants were required to 
decide whether or not each of eight successively presented words belonged to a 
particular semantic category (one of: fruits, vegetables, colours or household items).  
Participants made their category responses by pressing a key on the computer 
keyboard labelled ‘Y’ (Yes) or ‘N’ (No).  This categorisation task served simply to 
prevent rehearsal of the spatial location, and to ensure that participants continued to 
focus on the centre of the screen; these data were therefore not of interest in their 
own right, and have not been analysed.  After 10 seconds the eight (reference) black 
dots reappeared and participants were required to click the mouse on the dot 
occupying the position in which the target had previously appeared.  The next trial 
then commenced.  32 such experimental (SWM) trials were interspersed with 32 
sensorimotor control (SMC) trials in which the original target was displayed 
throughout the categorisation task and which thus imposed no demand on working 
memory.    Percentage correct and reaction time were recorded for both SWM and 
SMC trials. 
 
Verbal Fluency.  This has consistently been found to be sensitive to prefrontal lesions 
and is believed to tap strategic response generation or ‘willed action’ (e.g. 
Jahanshahi and Frith, 1998).  Here, participants were asked to generate as many 
words as they could beginning with either B or F (order counterbalanced across 
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conditions) in one minute, avoiding repetitions, proper nouns and the same word with 
different suffixes.  This single-letter version has good test-retest reliability and 
correlates highly with the traditional three-letter version (Harrison et al., 2000).   
 
Statistical analyses 
Data were analysed using repeated measures analysis of variance (ANOVA) with 
lozenge type (LOZTYPE: nicotine vs. placebo) as the within-subjects factor and order 
of lozenge administration as a between subjects factor (LOZORDER: nicotine first vs. 
placebo first).  Main effects or interactions involving LOZORDER are reported only 
where significant.  These analyses were also repeated with just the heavier smokers 
( 15 cigarettes per day) for direct comparability with the participants in our earlier 
study (Powell et al., 2002a).  In fact, however, we found no differences between the 
results for this sub-group and the full sample, thus here we present only those for the 
latter.   
 
Between-groups analyses were also conducted for time 1 data only, given that the 
blinding procedure was less successful at time 2 (see below); these are presented 
only where they yield findings which differ substantively than those from the full 
repeated measures analysis. 
 
Results 
 
Unless otherwise indicated all variables were normally distributed. 
 
Demographic and smoking-related variables: Summary statistics are shown in Table 
2.  The groups receiving nicotine and placebo lozenges in the two orders did not 
differ from each other in sex ratio (χ2 = 0.31, df = 1, ns), age (t143 < 1, ns), years in 
education (after age 16; t142 < 1.5, ns), or any of the smoking-related variables (t143 < 
1.6, ns in each case).    
 
Table 2 here 
 
 
Blinding: Participants were asked which lozenge (nicotine or placebo) they thought 
they had received at each testing session.  55% of participants guessed correctly at 
time 1, a figure not significantly different from chance level (χ2 = 1.67, ns), whilst 69% 
guessed correctly at time 2 (χ2 = 21.57, p < 0.001).   These figures suggest that the 
blinding procedure worked very well for participants at time 1 but less well at time 2 
 11
when participants had the benefit of mentally comparing the perceived effects of the 
lozenges across sessions. 
 
Craving, withdrawal and mood state: As shown in Table 3, both craving and 
withdrawal symptoms (MPSS score) were lower in the nicotine than placebo 
condition (craving: F1,143 = 21.95, p < 0.0001; MPSS: F1,143 = 6.65, p = 0.01). 
 
HADS Anxiety scores were significantly higher in the nicotine than placebo condition 
(F1,143 = 4.31, p < 0.05); although the scores were slightly elevated, in most cases 
they were well  within the normal range (Zigmond and Snaith 1983).  There was no 
effect of LOZTYPE on HADS Depression scores (F1,143 < 1, ns).   
 
Table 3 here  
 
Experimental tasks 
 
Oculomotor task (antisaccadic eye movements):  Saccade type (SACTYPE: 
prosaccade vs. antisaccade) was an additional within-subjects factor in the ANOVA.  
Summary data are shown in Figure 2. 
 
Figure 2 here  
 
The main effects of LOZTYPE (F1,120 = 30.0) and SACTYPE (F1,120 = 370.9) were 
both highly significant (p < 0.0001 in both cases), reflecting greater accuracy after 
nicotine than placebo, and in the prosaccade than antisaccade condition (see Figure 
2).  The LOZTYPE X SACTYPE interaction was also highly significant (F1,120 = 20.97, 
p < 0.0001), with nicotine improving performance more markedly in the  antisaccade 
than in the prosaccade condition.  This may be, to some extent, a function of ceiling 
level performance in the prosaccade trials. 
 
Continuous Performance Task (CPT): Table 4 shows summary data for the indices of 
accuracy (dprime), response bias (C) and motor errors (impulsive motor responses to 
filler stimuli).   
 
Table 4 here  
 
There was no main effect of LOZTYPE on either accuracy or response bias (F1,131 < 
1.5, ns, in each case).  LOZTYPE interacted significantly with LOZORDER for 
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accuracy (F1,131 = 10.49, p < 0.01) reflecting a strong practice effect from the first to 
the second testing session (time 1 mean dprime = 2.08, SD: 0.98; time 2 mean 
dprime = 2.28, SD: 1.03). This effect was also apparent, but less pronounced, for 
response bias (F1,131 = 3.58, p = 0.06) with a slight negative bias in the first session 
changing in the direction of a more neutral bias in the second session.  
 
Analysis of data at time 1 only revealed that participants receiving nicotine were more 
accurate than those receiving placebo (dprime: 2.22  1.02 and 1.91  0.90 
respectively; t133 = 1.82, p < 0.05 for a 1-tailed test), though there was no effect of 
LOZTYPE on response bias (t131 < 1, ns). 
 
For motor errors, there was a significant effect of LOZTYPE (F1,132 = 7.270, p < 0.01) 
reflecting a greater number of impulsive mouse clicks under placebo than nicotine.  
These data were positively skewed, with half of the participants making 3 or fewer 
errors, and so were re-analysed using the nonparametric Wilcoxon’s signed rank 
test.  This confirmed the effect as highly significant (Z = -3.16, p < 0.005).  Analysis of 
motor errors at time 1 only also revealed a highly significant effect (t133 = -3.18, p < 
0.005). 
 
Spatial Working Memory (SWM): Data were missing for two participants who had 
difficulty using the computer mouse.  TRIALTYPE (SWM vs. sensorimotor control 
[SMC] trials) was an additional within-subjects factor.  Summary data are shown in 
Table 5.  
 
Table 5 here 
 
 
For reaction time, there was a weak trend for responses to be faster after nicotine 
than placebo (LOZTYPE: F1,139 = 2.98, p = 0.09), and there was a significant effect of 
TRIALTYPE (F1,139 = 3.88, p = 0.05) with responses faster on SMC than SWM trials.  
However, there was no TRIALTYPE X LOZTYPE interaction (F1,139 < 1, ns).  
LOZORDER interacted significantly with LOZTYPE (F1,139 = 8.78, p < 0.005) 
reflecting a decrease in reaction time (i.e. a speeding of response) across testing 
sessions for both SMC and SWM trials.  However, the analysis of time 1 data only 
revealed no main or interactive effects of LOZTYPE (F1,140 < 1, ns).  
 
For percentage correct (the measure of accuracy), the main effect of LOZTYPE was 
significant (F1,139 = 6.26, p = 0.01) reflecting greater accuracy overall after nicotine.  
The main effect of TRIALTYPE was also significant (F1,139 = 152.42, p < 0.0001), with 
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greater accuracy on SMC trials.  There was, however, no significant LOZTYPE X 
TRIALTYPE interaction (F1,139 < 1, ns).  Again, the LOZORDER X LOZTYPE 
interaction was significant (F1,139 = 8.97, p < 0.005) reflecting a greater enhancement 
by nicotine in the group receiving it second.  The LOZTYPE X TRIALTYPE 
interaction also fell short of significance in the between-groups comparison at time 1 
(F1,140 = 1.96, ns).   
 
Verbal Fluency: There was no significant effect of LOZTYPE (F1,141 < 1, ns; nicotine, 
14.95 ± 4.94 words, placebo 14.75 ± 5.25 words).  A between-groups t-test at time 1 
did however reveal a significant effect of LOZTYPE, but in the opposite direction from 
that predicted: performance was better in the placebo condition (t142 = -2.45, p < 0.05; 
placebo 15.8 ± 5.5 vs. nicotine 14.0 ± 4.4 words).  This effect remained significant 
even when four outliers (± 2 sds from the mean) were excluded.   
 
Associations between measures of smoking dependence and cognitive 
variables 
 
In order to determine whether nicotine was more effective in enhancing performance 
in more severely dependent smokers, we computed correlations between two indices 
of nicotine dependence (baseline salivary cotinine and FTND scores) and change 
scores (nicotine minus placebo) on those cognitive tasks that showed a beneficial 
effect of nicotine lozenge (i.e. antisaccades percentage accuracy; CPT motor errors; 
SWM percentage correct; and SMC percentage correct). 
 
Antisaccadic accuracy correlated significantly and positively with both baseline 
salivary cotinine (r = 0.23, p< 0.01) and FTND scores (r = 0.25, p < 0.01); that is, 
more heavily dependent smokers showed greater enhancement of performance by 
nicotine compared with placebo.  All other correlations fell short of significance.  
 
Discussion 
 
The results from this placebo-controlled double-blind study are generally consistent 
with our first hypothesis, that acute smoking abstinence would be associated with 
impaired response inhibition relative to performance after nicotine, and corroborate 
our previous observations when nicotine was administered by smoking (Powell et al. 
2002).  The fact that in this study nicotine was administered in lozenge form under 
double-blind conditions, with guessing by participants at chance level in the first (but 
not the second) testing session, strongly suggests that the performance 
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enhancement seen both here and in our previous studies is attributable to nicotine 
and not either to some other constituent of tobacco or to expectancy effects.   
 
On the oculomotor (antisaccade) task, as in our previous study (Powell et al. 2002) 
participants made more erroneous reflexive glances towards the peripheral stimulus 
during abstinence (placebo condition) than after nicotine. Furthermore, the extent to 
which nicotine ameliorated poor response inhibition was modestly correlated with 
degree of nicotine dependence as measured by salivary cotinine and FTND scores. 
This raises the interesting possibilities either that some individuals are more sensitive 
to the effects of nicotine and that this increases their susceptibility to developing 
dependence, or conversely that this effect of nicotine develops alongside – and 
reflects – increases in dependence. 
 
The impaired inhibitory control of oculomotor responses during abstinence observed 
here is consistent with neuroimaging studies which have demonstrated reduced DA 
activity in PFC/ACG in chronic drug users, and with current neurobiological models of 
addiction (e.g. Jentsch & Taylor, 1999; Goldstein & Volkow, 2002.  For instance, in 
their I-RISA model, Goldstein and Volkow describe addiction as a ‘cortically regulated 
cognitive and emotional process’ that manifests behaviourally in impaired inhibitory 
control over responses to drug-related stimuli.  The present data suggest that such  
deficits may be part of a more generalised impairment which encompasses control 
over reflexive responses to non drug-related stimuli, and that they are particularly 
marked during acute abstinence.  That nicotine lozenges can attenuate this deficit 
may contribute to the effectiveness of nicotine replacement therapy (NRT) in 
increasing abstinence rates.  Whether poor inhibitory control resurfaces following 
withdrawal of NRT is an important clinical question, since this might help to explain 
the subsequent elevation in relapse risk. 
 
Impaired response inhibition was also manifest on the continuous performance task 
(CPT) in that abstinent smokers made more motor errors (responses to to-be-ignored 
fillers) after placebo than nicotine.  By contrast, however, we found no effect of 
nicotine/abstinence on our response bias measure (C), which has been argued to 
reflect the propensity to respond impulsively (Dougherty et al. 1999).   
 
A few previous studies have explored the effects of nicotine and abstinence on 
indices of response inhibition, with rather mixed findings. In non-smokers, Levin et al. 
(1998) found nicotine to reduce the frequency of omission errors on the CPT without 
any increase in commission errors.  In smokers, Hatsukami et al. (1989) found 
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increased rates of commission errors after 24 hours abstinence, though Bekker et al. 
(2005) found no benefit of nicotine following overnight abstinence on commission 
errors on two different versions of the CPT, or on successful ‘stops’ on a stop-signal 
task.  On the other hand, in minimally (c. 2 hour) abstinent smokers Edginton & 
Rusted (2003) reported nicotine to enhance the inhibition of task-irrelevant material 
on a retrieval-induced forgetting task, whilst Rycroft et al. (2005) found a similar 
increase in efficiency on a visual search task which was attributable to better 
inhibition of eye movements towards distractor stimuli. 
 
Discrepancies between studies could reflect a number of methodological variations, 
including for example route of nicotine administration or degree of nicotine 
dependence.  One theoretically interesting possibility, however, is that tasks showing 
apparently contradictory results tap different facets of inhibitory control.  Several 
authors have proposed conceptually important distinctions.  For instance, Nigg 
(2000) has proposed a working taxonomy with the following classes of executive 
response inhibition: interference control (resource/response competition), cognitive 
inhibition (of irrelevant information in working memory), behavioural inhibition (of 
prepotent responses) and oculomotor inhibition (of reflexive saccades).   Under this 
taxonomy, response bias on the CPT (C) might correspond most closely to 
interference control whilst impulsive motor errors (responses to the filler stimuli) 
represent a failure of behavioural inhibition.  This analysis suggests that the inhibitory 
control deficits observed during nicotine abstinence may relate specifically to 
prepotent motor (including oculomotor) responses rather than extending more 
generally to cognitively mediated reactions.  An interesting direction for future 
empirical research would be to compare the effects of abstinence and drug 
administration on a range of measures designed specifically to tap the different 
categories of response inhibition.  
 
With respect to our second hypothesis, we found mixed evidence for the predicted 
effects of abstinence and nicotine on other tasks of executive functioning.  Spatial 
working memory (SWM) was assessed using a delayed response task, performance 
on which has been associated with DLPFC activity (Funahashi et al. 1989), and was, 
as predicted, impaired during abstinence relative to the nicotine condition.  However, 
the effect of nicotine was not specific to SWM trials but affected sensorimotor control 
(SMC) trials equally. This suggests that whilst nicotine did improve working memory 
performance in these abstinent smokers, it probably did so via a general effect on 
attention or efficiency of information-processing.  Interestingly, the beneficial effect of 
nicotine on both SWM and SMC trials disappeared when five participants with very 
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poor performance (more than three standard deviations below the mean) were 
excluded.  This observation is consistent with the conclusions of a review by 
Newhouse et al. (2004) which led the authors to conclude that any performance-
enhancing effects of nicotine are likely to be greatest in individuals whose functioning 
is sub-optimal. 
 
Previous studies using the SWM task have yielded rather inconsistent results.  Thus 
Ernst et al. (2001) reported no difference in performance between abstaining- and 
ex-smokers, despite differential patterns of regional brain activity; whilst in direct 
contradiction to the present data, Park et al. (2000) found that smoking a single 
cigarette after 24 hour abstinence had an adverse effect on SWM in regular smokers.  
There were some differences between the two studies; for instance, in Park et al.’s 
study the duration of abstinence was longer, nicotine was given by cigarette rather 
than lozenge, and the SWM task was repeated under abstinent and nicotine 
conditions within a single session.  It may be, for example, that the rapid and strong 
effect of a bolus of nicotine after rather 24 hours abstinence produces somatic and 
cognitive effects which are quite different from those achieved by the slower lozenge 
delivery mechanism used here (cf. Hukkanen et al., 2005). 
  
The dprime index of accuracy on the CPT task can also be interpreted as tapping 
working memory.  Here, there was some evidence that nicotine increased accuracy, 
though this effect emerged only when the analysis was restricted to scores on the 
first testing occasion; there is a strong practice effect on this task which may have 
weakened the ability to detect a nicotine effect on the second assessment. However, 
dprime is also sensitive to attention and general efficiency of information-processing; 
these findings, like those from the SWM task, can therefore be explained via an 
effect of nicotine on general alertness and information-processing efficiency, rather 
than specifically on executive functioning.  
 
Finally, we found no support for the predicted beneficial effect of nicotine on another 
well-established aspect of executive functioning: verbal fluency. Indeed, counter to 
expectation, between-groups analysis of time 1 data only revealed superior 
performance during abstinence.   This is difficult to explain, but may well be spurious 
as we have previously found inconsistent results for the effects of smoking vs. 
abstinence on this task: in one study performance improved after smoking (Al-Adawi 
and Powell, 1996) whilst in another there was no such effect (Powell et al. 2002).    
 
To conclude, although this study has found little support for a broad deficit of 
executive functioning during nicotine abstinence in regular smokers, it has yielded 
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persuasive evidence for an impairment of inhibitory control over reflexive motor and 
oculomotor responses that can be reversed with nicotine administration.  Since 
response inhibition is commonly attributed to anterior cingulate function (e.g. Volkow 
et al. 2004) it may be that functioning of this particular region more than neighbouring 
areas is disrupted in chronic smokers.  Elucidation of the exact nature of the 
inhibitory deficits, their potential relevance to relapse, and the extent to which they 
also characterise addicts recently withdrawn from other substances (e.g. alcohol, 
cocaine, heroin) may prove to be fruitful avenues for future research. 
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Table 1 
 
ASSESSMENT ORDER OF TESTS 
Baseline Informed consent 
Demographic information 
Expired carbon monoxide  
Tridimensional Personality Questionnaire 
Fagerström Test of Nicotine Dependence 
Sensation Seeking Questionnaire 
Hospital Anxiety and Depression Scale (HADS) 
Eysenck Personality Questionnaire 
Smoking Motivation Questionnaire 
IVE 
Positive Emotionality Quesionnaire 
Salivary Cotinine 
2 to 7 days later 
Assessment 1  
Following overnight (12 
hours) abstinence  
 
 
Group 1: Nicotine lozenge 
Group 2: Placebo lozenge 
Expired carbon monoxide (must be ≤ 10ppm) 
Administration of lozenge + 30 minute wait 
Spatial Working Memory Task 
Oculomotor (saccade) Task 
Verbal Fluency test 
Antisaccadic Eye Movement Task 
Administration of ‘top-up’ lozenge 
CARROT or IMERS task (counterbalanced) 
Alphabet Arithmetic 
HADS 
Snaith Hamilton Pleasure Scale (SHAPS) 
Stroop  
IMERS or CARROT (counterbalanced) 
Continuous Performance Task* 
Cue Reactivity [craving and withdrawal symptoms] 
One week later 
Assessment 2 
Following overnight (12 
hours) abstinence 
 
 
Group 1: Placebo lozenge 
Group 2: Nicotine lozenge 
 
 
Expired carbon monoxide (must be ≤ 10ppm) 
Administration of lozenge + 30 minute wait 
Spatial Working Memory Task 
Oculomotor (saccade) Task 
Verbal Fluency test 
Antisaccadic Eye Movement Task 
Administration of ‘top-up’ lozenge 
CARROT or IMERS task (counterbalanced) 
Alphabet Arithmetic  
HADS 
Snaith Hamilton Pleasure Scale (SHAPS) 
Stroop  
IMERS or CARROT (counterbalanced) 
Continuous Performance Task* 
Cue Reactivity [craving and withdrawal symptoms] 
Procedures/assessment measures in bold represent those relevant to the present 
study.  
* This task was not available for the first 12 subjects 
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Table 2 
 
  
All participants  
N = 145 
 
Age 
   Mean (SD) 
   Range 
 
31.90 (12.28) 
18-65 
Sex ratio (M:F) 63:82 
Years in education (post 16yrs) 
   Mean (SD) 
   Range 
 
3.84 (3.28) 
0-22 
No. of cigarettes per day 
   Mean (SD) 
   Range 
 
18.05 (5.82) 
10-40 
Years of regular smoking 
   Mean (SD) 
   Range  
 
15.71 (12.33) 
1-52 
No. of previous quit attempts 
   Mean (SD) 
   Range 
 
2.75 (3.25) 
0-20 
Baseline cotinine 
   Mean (SD) 
   Range 
 
266.59 (151.39) 
43.60-940.30 
FTND 
   Mean (SD) 
   Range 
 
4.92 (1.83) 
1-9 
 
FTND = Fagerstrom Test of Nicotine Dependence 
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Table 3 
 
  
Placebo Lozenge 
 
Nicotine Lozenge 
 
Craving 
   Mean (SD) 
   Range  
 
3.99 (1.75) 
1-7 
 
3.29 (1.66) 
1-7 
MPSS 
   Mean (SD) 
   Range 
 
7.12 (5.12) 
0-42 
 
6.04 (4.32) 
0-21 
HADS – Anxiety 
   Mean (SD) 
   Range 
 
6.69 (3.50) 
0-17 
 
7.16 (3.92) 
0-20 
HADS – Depression 
   Mean (SD) 
   Range 
 
4.26 (2.93) 
0-13 
 
4.12 (2.95) 
0-16 
 
MPSS:  Mood and Physical Symptoms Scale 
HADS: Hospital Anxiety and Depression Scale 
 
 25
  
 
Table 4 
 
CPT task variable 
 
Placebo Lozenge 
 
Nicotine Lozenge 
 
D’ (dprime): 
  Mean (SD) 
 
2.15 (1.04) 
 
2.21 (0.98) 
C: 
  Mean (SD) 
 
-0.02 (0.41) 
 
-0.05 (0.41) 
No. of motor errors 
  Mean (SD) 
 
5.82 (5.73) 
 
4.58 (4.85) 
 
D’:  Measure of accuracy in discriminating targets from catch stimuli (range 0 to 4) 
C: Criterion location index of response bias (0 = unbiased, negative = 
liberal/impulsive, positive = cautious) 
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 Table 5 
 
SWM Task variable 
 
Placebo Lozenge 
 
Nicotine Lozenge 
 
RT SMC trials 
  Mean (SD) 
 
1326.56 (662.03) 
 
1280.07 (483.00) 
RT SWM trials 
  Mean (SD) 
 
1346.73 (723.62) 
 
1300.48 (560.69) 
   
% correct SMC trials 
  Mean (SD)  
 
97.66 (8.76) 
 
98.76 (4.80) 
% correct SWM trials 
  Mean (SD) 
 
86.14 (17.04) 
 
88.03 (13.79) 
 
RT = reaction time (msec) 
SMC = sensorimotor control  
SWM = spatial working memory 
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Figure 1 
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Legend for Tables and Figures 
Table 1: Schematic overview of design and order of assessments 
Table 2: Demographic and smoking-related information 
Table 3: Mean (SD) self-reported craving, withdrawal symptoms (MPSS) and HADS 
Anxiety and Depression scores under nicotine and placebo lozenge 
conditions.  
Table 4: Means for Continuous Performance Task (CPT) variables under nicotine 
and placebo lozenge conditions. 
Table 5: Spatial Working Memory task means (SD) under nicotine and placebo 
lozenge conditions 
 
 
Figure 1: CPT task experimental framework.   
Figure 2: Percentage correct on the Antisaccade and Prosaccade Tasks under 
conditions of nicotine and placebo lozenge. Error bars are +/- 1SE 
 
 
 
 
